66 related articles for article (PubMed ID: 28212844)
1. Thyroid stimulating hormone increases hepatic gluconeogenesis via CRTC2.
Li Y; Wang L; Zhou L; Song Y; Ma S; Yu C; Zhao J; Xu C; Gao L
Mol Cell Endocrinol; 2017 May; 446():70-80. PubMed ID: 28212844
[TBL] [Abstract][Full Text] [Related]
2. CRTC2 Is a Coactivator of GR and Couples GR and CREB in the Regulation of Hepatic Gluconeogenesis.
Hill MJ; Suzuki S; Segars JH; Kino T
Mol Endocrinol; 2016 Jan; 30(1):104-17. PubMed ID: 26652733
[TBL] [Abstract][Full Text] [Related]
3. Ceramide enhanced the hepatic glucagon response through regulation of CREB activity.
Wang J; Wang D; Lu S; Hu Y; Ge Y; Qin X; Mo Y; Kan J; Li D; Zhang R; Liu Y; Zhang WS
Clin Nutr; 2024 Feb; 43(2):366-378. PubMed ID: 38142481
[TBL] [Abstract][Full Text] [Related]
4. RNAi screening in primary human hepatocytes of genes implicated in genome-wide association studies for roles in type 2 diabetes identifies roles for CAMK1D and CDKAL1, among others, in hepatic glucose regulation.
Haney S; Zhao J; Tiwari S; Eng K; Guey LT; Tien E
PLoS One; 2013; 8(6):e64946. PubMed ID: 23840313
[TBL] [Abstract][Full Text] [Related]
5. A novel role for CRTC2 in hepatic cholesterol synthesis through SREBP-2.
Li Y; Song Y; Zhao M; Guo Y; Yu C; Chen W; Shao S; Xu C; Zhou X; Zhao L; Zhang Z; Bo T; Xia Y; Proud CG; Wang X; Wang L; Zhao J; Gao L
Hepatology; 2017 Aug; 66(2):481-497. PubMed ID: 28395113
[TBL] [Abstract][Full Text] [Related]
6. Thyroid Stimulating Hormone Triggers Hepatic Mitochondrial Stress through Cyclophilin D Acetylation.
Wang X; Mao J; Zhou X; Li Q; Gao L; Zhao J
Oxid Med Cell Longev; 2020; 2020():1249630. PubMed ID: 31998431
[TBL] [Abstract][Full Text] [Related]
7. Abnormal Glucose Metabolism and Insulin Resistance Are Induced via the IRE1α/XBP-1 Pathway in Subclinical Hypothyroidism.
Xu C; Zhou L; Wu K; Li Y; Xu J; Jiang D; Gao L
Front Endocrinol (Lausanne); 2019; 10():303. PubMed ID: 31156553
[TBL] [Abstract][Full Text] [Related]
8. TSH Activates Macrophage Inflammation by G13- and G15-dependent Pathways.
Yang C; He Z; Zhang Q; Lu M; Zhao J; Chen W; Gao L
Endocrinology; 2021 Aug; 162(8):. PubMed ID: 33851697
[TBL] [Abstract][Full Text] [Related]
9. TSH promotes adiposity by inhibiting the browning of white fat.
Zhang J; Wu H; Ma S; Gao L; Yu C; Jing F; Zhao J
Adipocyte; 2020 Dec; 9(1):264-278. PubMed ID: 32579056
[TBL] [Abstract][Full Text] [Related]
10. Thyrotropin aggravates atherosclerosis by promoting macrophage inflammation in plaques.
Yang C; Lu M; Chen W; He Z; Hou X; Feng M; Zhang H; Bo T; Zhou X; Yu Y; Zhang H; Zhao M; Wang L; Yu C; Gao L; Jiang W; Zhang Q; Zhao J
J Exp Med; 2019 May; 216(5):1182-1198. PubMed ID: 30940720
[TBL] [Abstract][Full Text] [Related]
11. Cholesterol-induced toxicity: An integrated view of the role of cholesterol in multiple diseases.
Song Y; Liu J; Zhao K; Gao L; Zhao J
Cell Metab; 2021 Oct; 33(10):1911-1925. PubMed ID: 34562355
[TBL] [Abstract][Full Text] [Related]
12. Maternal nutrient metabolism in the liver during pregnancy.
Fang H; Li Q; Wang H; Ren Y; Zhang L; Yang L
Front Endocrinol (Lausanne); 2024; 15():1295677. PubMed ID: 38572473
[TBL] [Abstract][Full Text] [Related]
13. Co-Morbid Hypothyroidism and Liver Dysfunction: A Review.
Yorke E
Clin Med Insights Endocrinol Diabetes; 2024; 17():11795514241231533. PubMed ID: 38348020
[TBL] [Abstract][Full Text] [Related]
14. CRTC2 activates the epithelial-mesenchymal transition of diabetic kidney disease through the CREB-Smad2/3 pathway.
Li Y; Zhang Y; Shi H; Liu X; Li Z; Zhang J; Wang X; Wang W; Tong X
Mol Med; 2023 Oct; 29(1):146. PubMed ID: 37884902
[TBL] [Abstract][Full Text] [Related]
15. Thyroid-stimulating hormone may participate in insulin resistance by activating toll-like receptor 4 in liver tissues of subclinical hypothyroid rats.
Bao S; Li F; Duan L; Li J; Jiang X
Mol Biol Rep; 2023 Dec; 50(12):10637-10650. PubMed ID: 37884783
[TBL] [Abstract][Full Text] [Related]
16. Understanding the Relationship between Nonalcoholic Fatty Liver Disease and Thyroid Disease.
Vidal-Cevallos P; Murúa-Beltrán Gall S; Uribe M; Chávez-Tapia NC
Int J Mol Sci; 2023 Sep; 24(19):. PubMed ID: 37834051
[TBL] [Abstract][Full Text] [Related]
17. Biological functions of CRTC2 and its role in metabolism-related diseases.
Zheng HY; Wang YX; Zhou K; Xie HL; Ren Z; Liu HT; Ou YS; Zhou ZX; Jiang ZS
J Cell Commun Signal; 2023 Sep; 17(3):495-506. PubMed ID: 36856929
[TBL] [Abstract][Full Text] [Related]
18. Atypical pituitary hormone-target tissue axis.
Xu C; He Z; Song Y; Shao S; Yang G; Zhao J
Front Med; 2023 Feb; 17(1):1-17. PubMed ID: 36849623
[TBL] [Abstract][Full Text] [Related]
19. Effects of Anterior Pituitary Adenomas' Hormones on Glucose Metabolism and Its Clinical Implications.
Li M; Zhang J; Yang G; Zhang J; Han M; Zhang Y; Liu Y
Diabetes Metab Syndr Obes; 2023; 16():409-424. PubMed ID: 36816815
[TBL] [Abstract][Full Text] [Related]
20. X-box binding protein 1: A new metabolic mediator and drug target of metformin?
Lou K; Sun P; Zhang C; Jiang Q; Pang S
Front Pharmacol; 2022; 13():1013218. PubMed ID: 36438823
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
